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S U M M A R Y
Background: Chikungunya fever (CGF) and rickettsioses are known to cause acute onset febrile illnesses
associated with severe arthritis. Rickettsial arthritis is curable with the use of appropriate anti-rickettsial
antibiotics, however the arthritis of CGF tends to have a prolonged course leading to protracted
disability. The aim of this study was to investigate the contribution of CGF and rickettsioses to cases of
fever and arthritis during a presumed CGF outbreak in Sri Lanka.
Methods: Fifty-eight consecutive patients with presumed CGF were further investigated to determine the
occurrence of rickettsioses among them, and to identify differences in clinical, hematological, and
biochemical parameters between the two diseases.
Results: Nearly a third of the patients had serological evidence of rickettsioses accounting for their
illness. The presence of a late onset major joint arthropathy sparing the small joints of the hands and feet,
and the occurrence of a late onset discrete maculopapular rash over the trunk and extremities, suggested
rickettsioses over CGF. White blood cell count, erythrocyte sedimentation rate, C-reactive protein, and
liver function tests were not helpful in differentiating rickettsioses from CGF. Patients with rickettsioses
and arthritis who received an empirical course of doxycycline recovered faster than those who did not
receive speciﬁc treatment.
Conclusions: The establishment of rapid diagnostic methods able to differentiate the etiological agents of
fever and arthritis, such as CGF and rickettsioses, would be beneﬁcial in endemic settings.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Chikungunya fever (CGF) is caused by an arbovirus transmitted
by the Aedes aegypti mosquito.1 The illness is characterized by an
acute onset febrile illness associated with severe arthritis involving
both major and small joints of the body. Although fever seems to
subside over 5–7 days, similar to most other viral fevers, the
incapacitating arthritis tends to persist for a variable period of time
– commonly for about 3 months, but sometimes up to 1 year or
more.2–4 In addition to fever and arthritis, an erythematous
blanching rash is seen during the early illness, and some patients
also develop an erythematous maculopapular rash over the body,
mainly involving the limbs and the trunk.5 Since the illness is viral
there is no effective speciﬁc treatment.* Corresponding author. Tel.: +94 11 2958039 ext. 119.
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with varying degrees of arthralgia and arthritis.6 Some, especially
the spotted fever group (SFG) rickettsioses, are associated with an
erythematous maculopapular rash.6,7 Although rickettsioses com-
monly cause arthralgia,6 incapacitating major joint arthritis has
also been recognized.8 Unlike in CGF, patients with rickettsial
arthritis recover rapidly with anti-rickettsial antibiotics.8
Sri Lanka experienced a major outbreak of CGF from mid 2006 to
early 2008.9 Patients presented with characteristic fever, severe
arthritis, and sometimes a maculopapular rash. The outbreak was
conﬁrmed to be due to the chikungunya virusby isolation of the virus
by PCR.9 However due to the rapid spread of the illness throughout
the island and the non-availability or non-affordability of conﬁrma-
tory tests, most patients with fever and arthritis during this period
were presumed to have CGF and were treated only symptomatically.
As rickettsioses are re-emerging in most parts of Sri Lanka, we
carried out a retrospective study to investigate the contribution of
rickettsioses in a group of patients with fever and arthritis,
presumed to be due to CGF.ses. Published by Elsevier Ltd. All rights reserved.
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Fifty-eight consecutive patients with presumed CGF who
attended an outpatient clinic in Ragama, Western Sri Lanka, were
further investigated. Of these patients, only 45 attended the second
clinic visit at 2 weeks, and only 31 attended the third visit at 4
weeks. Clinical details were recorded at each clinic visit using a
pre-tested questionnaire. A 3-ml serum sample was obtained
during the ﬁrst or second clinic visit (in order to ensure an interval
of at least 7 days between the onset of the clinical illness and
obtaining the serum) and follow-up serum sample were obtained
at 8 weeks and 6 months after the initial presentation. All serum
samples were stored at 70 8C before analysis for serological
evidence of rickettsioses and CGF. The 31 patients were followed
up by telephone interview until signiﬁcant improvement of
symptoms was reported.
Immuno ﬂuorescent antibody assays (IFA) were carried out
using rickettsial antigens prepared from cell culture-grown
rickettsiae: Rickettsia conorii (Malish), Rickettsia typhi (Wilming-
ton), and Orientia tsutsugamushi (Karp). IgM and IgG antibodies
were detected using ﬂuorescein-conjugated goat anti-human
IgG(g) and IgM (KPL, Inc., Gaithersburg, MD, USA). Serum was
screened at 1/32, and positive samples were titered to an endpoint
of 1:2048 for IgG. Acute rickettsial infection was deﬁned by the
presence of an IFA IgM titer of 1/64 combined with a positive IgG
titer of 1:128 and either a four-fold increase or decrease in IgG
titers in the follow-up samples.
Serum was also tested for chikungunya virus infection.
Serological evidence of acute CGF was deﬁned as a positive OnSite
Chikungunya IgM Rapid Test (CTK Biotech Inc., USA), carried out in
accordance with the manufacturer’s instructions. Serological tests
were carried out at the Rickettsial Disease Research and DiagnosticTable 2
Comparison of clinical, hematological, and biochemical parameters between chikungun
Clinical parameter 
Duration of illness at the time of ﬁrst presentation for medical care (days) 
Days to occurrence of arthritis from onset of fever 
Days to occurrence of rash from onset of fever 
Major joint involvement, n 
Small joint involvement, n 
WBC (after 4th day; cells  109/l) 
Platelet count (cells  109/l) 
ESR (mm/h) 
CRP (mg/dl) 
AST (IU/l) 
ALT (IU/l) 
WBC, white blood cell count; ESR, erythrocyte sedimentation rate; CRP, C-reactive pro
a Results are mean (standard deviation) unless stated otherwise.
Table 1
Serological titers of patients who were positive for rickettsioses
Acute serology 
CKG OT IgG OT IgM RC IgG 
1 Neg 1:256 
2 Neg 1:256 
3 Neg 1:256 
4 Neg 1:256 
5 1:256 1:64 1:256 
6 1:512 
7 1:1024 
8 Pos 1:256 1:64 
9 1:256 1:64 
10 1:2048 1:128 
11 1:256 
CKG, chikungunya virus; OT, Orientia tsutsugamushi; RC, Rickettsia conorii; R. typhi, Ric
a At 6 months.Laboratory, Faculty of Medicine, University of Kelaniya and Faculty
of Veterinary Medicine, University of Peradeniya, Sri Lanka.
A full blood count, erythrocyte sedimentation rate, C-reactive
protein levels, and liver function tests were also performed at the
ﬁrst clinic visit, if they had not already been done.
Statistical analysis of clinical, biochemical, and hematological
parameters in the two populations of patients were done using
Stata 8.2 (Stata Corp., College Station, TX, USA). Statistical
signiﬁcance was assessed using the Wilcoxon rank sum test for
numeric variables. Ethical clearance for the study was obtained
from the Ethics Review Committee, Faculty of Medicine, University
of Kelaniya.
3. Results
Of the 31 patients who were investigated, 14 were male and 17
female; their mean age was 36.2 years (standard deviation 4.7
years). Ten of these patients had serological evidence of acute
rickettsioses (Table 1), 16 had evidence of acute CGF, one had
evidence of both CGF and acute O. tsutsugamushi infection (case 8),
and four were negative for both. Out of the 10 who were positive for
acute rickettsioses, eight were positive for acute SFG rickettsioses
and two had serological evidence of acute O. tsutsugamushi; none
were positive for R. typhi.
The comparison of clinical and biochemical parameters
between rickettsioses and CGF is shown in Table 2.
Although all patients had a variable clinical recovery over 2 to
16 weeks, only ﬁve of the 10 cases of rickettsioses (four SFG and
one O. tsutsugamushi) received doxycycline on an empirical basis
due to the lack of diagnostic facilities (rickettsial disease
diagnostics had not yet been established in Sri Lanka in June
2008). None of the patients with CGF received doxycycline. Amongya fever and rickettsiosesa
Rickettsioses Chikungunya fever p-Value
8.3 (3.2) 2.8 (0.9) <0.001
6.5 (1.2) 2.4 (0.9) <0.001
7.2 (2.4) (n = 5/10) 3.2 (1.1) (n = 9/16) <0.001
10/10 14/16 0.6
4/10 13/16 0.01
5.4 (1.3) (n = 10) 4.9 (1.9) 0.28
128 (10) 92 (14) <0.001
51.5 (5) 46.1 (8) 0.48
52 (12) 59.4 (5.3) 0.45
58.3 (12.4) 62.3 (10.5) 0.52
62.2(10.3) 59.7 (11.2) 0.58
tein; AST, aspartate aminotransferase; ALT, alanine aminotransferase.
Convalescent serology after
8 weeks/6 months
RC IgM R. typhi IgG OT-IgG RC-IgG
1:64 Neg 1:128/1:64a
1:64 Neg 1:128/1:64a
1:64 Neg ND/1:64a
1:128 Neg 1:64/1:64a
1:64 Neg 1:128a ND/1:64a
1:128 Neg 1:64
1:128 Neg 1:64
Neg 1:128/1:64a
Neg 1:64
Neg 1:128
1:64 Neg 1:128/1:64a
kettsia typhi; ND, not determined.
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made a quicker recovery (within 4 days) compared to the patients
who were not treated with doxycycline (mean 16 days).
4. Discussion
In this study, we found that among patients with clinically
presumed CGF, 10 (32%) had conﬁrmed rickettsioses. Patients with
rickettsioses mainly had late onset, major joint arthritis, with
lesser involvement of the small joints of the hands and feet,
compared to patients with CGF. The early onset severe arthritis in
CGF is the likely reason for these patients seeking treatment earlier
in the illness than those with rickettsioses. In addition to arthritis,
patients with CGF had a conﬂuent erythematous maculopapular
rash over the trunk and limbs compared to a more discrete rash in
rickettsioses. We could not ﬁnd any hematological or biochemical
test that would be useful to differentiate rickettsioses from CGF,
except that CGF patients had signiﬁcantly lower platelet counts. In
the patients with rickettsioses, those who were treated with
doxycycline made a quicker recovery from the arthritis than those
who did not receive speciﬁc treatment.
With regard to the hematological investigations, the platelet
count in rickettsioses was signiﬁcantly higher compared to that in
CGF. However we could not establish a cut-off level for platelets for
the prediction of rickettsioses over CGF due to the small number of
cases in this study. Furthermore, we have seen very low platelet
counts in patients with rickettsioses. Although rickettsioses are
caused by bacteria and CGF is caused by a virus, we could not ﬁnd
any signiﬁcant difference in white blood cell counts between the
two groups. The reason behind this could be that patients with
rickettsioses are known to present with a hematological picture
similar to a viral infection, with low white blood cell counts and
reactive lymphocytosis.10 Similarly, none of the other biochemical
tests used in this study were helpful in differentiating CGF and
rickettsioses.
Therefore, we feel that the presence of early onset small joint
arthritis in addition to major joint involvement and the occurrence
of a more conﬂuent early onset erythematous maculopapular rash
over the trunk and limbs would help to differentiate CGF from
rickettsioses among patients with acute onset fever and arthritis.
The early clinical response of arthritis in patients who were
positive for rickettsioses and received doxycycline compared to
those who did not receive doxycycline may have been due to early
recovery from infection or the immunomodulatory or anti-
inﬂammatory properties of doxycycline.11–13 However none of
the patients who were positive for CGF received doxycycline.
Therefore, it is difﬁcult to comment on the immunomodulatory
properties of doxycycline in patients with CGF arthritis.
The role of serology in the diagnosis of rickettsioses during the
acute phase of illness is doubtful until current deﬁciencies of the
serological tests in relation to an endemic setting are sorted out.
Furthermore, although microimmunoﬂuorescence-based (IFA)
IgM and IgG detection is considered the gold standard in the
diagnosis of acute rickettsioses,14 IFA diagnostics against R. typhi
are known to cause non-speciﬁc cross-reactivity with other
bacterial antigens such as Proteus vulgaris OX19 and Legionella
bozemanii.15 However such cross-reactivity has not been demon-
strated between rickettsioses and arboviruses such as chikungu-
nya virus. Therefore, it is likely that these patients were sufferingfrom either rickettsioses or CGF. It is unlikely that immunomod-
ulatory effects of doxycycline interfered with the initial serologi-
cal results in patients with acute rickettsioses, because at the time
the ﬁrst serum sample was obtained, none of the patients had
received doxycycline. It is difﬁcult to comment on how such
treatment could have interfered with follow-up serology. None of
the patients who were positive for CGF received doxycycline.
Considering the limitations of IFA-based diagnostics in the
diagnosis of acute rickettsioses, PCR-based diagnostic facilities
would be the best to differentiate the two illnesses early. However
their availability and cost may interfere with their value in most
endemic settings. Therefore, in areas where PCR-based diagnostic
facilities are not available, an empirical treatment with doxycy-
cline would be helpful in managing these patients.
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